Simplex Trading
CAPR icon

Simplex Trading’s Capricor Therapeutics CAPR Stock Holding History

Simplex Trading’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.31M Buy
109,000
+37,300
+52% +$994K ﹤0.01% 1420
2025
Q4 		$2.07M Sell
71,700
-254,800
-78% -$3.33M ﹤0.01% 1951
2025
Q3 		$2.35M Sell
326,500
-150,400
-32% -$1.11M ﹤0.01% 2153
2025
Q2 		$4.74M Buy
476,900
+424,600
+812% +$4.49M ﹤0.01% 1391
2025
Q1 		$496K Sell
52,300
-241,600
-82% -$3.35M ﹤0.01% 3417
2024
Q4 		$4.05M Buy
293,900
+122,800
+72% +$2.15M ﹤0.01% 1628
2024
Q3 		$2.6M Buy
171,100
+139,800
+447% +$691K ﹤0.01% 2050
2024
Q2 		$149K Buy
31,300
+22,400
+252% +$125K ﹤0.01% 4937
2024
Q1 		$60K Sell
8,900
-30,900
-78% -$149K ﹤0.01% 6096
2023
Q4 		$194K Buy
39,800
+3,800
+11% +$12.4K ﹤0.01% 4710
2023
Q3 		$123K Buy
36,000
+500
+1% +$2.81K ﹤0.01% 4881
2023
Q2 		$169K Sell
35,500
-38,200
-52% -$168K ﹤0.01% 4489
2023
Q1 		$311K Sell
73,700
-5,300
-7% -$22.8K ﹤0.01% 3804
2022
Q4 		$304K Buy
79,000
+28,700
+57% +$137K ﹤0.01% 3726
2022
Q3 		$301K Buy
50,300
+28,400
+130% +$145K ﹤0.01% 4074
2022
Q2 		$76K Sell
21,900
-9,600
-30% -$34.1K ﹤0.01% 5943
2022
Q1 		$108K Buy
31,500
+20,100
+176% +$79.3K ﹤0.01% 6021
2021
Q4 		$33K Sell
11,400
-7,400
-39% -$25.9K ﹤0.01% 7762
2021
Q3 		$95K Sell
18,800
-400
-2% -$1.82K ﹤0.01% 6681
2021
Q2 		$98K Buy
19,200
+18,795
+4,641% +$79.6K ﹤0.01% 6750
2021
Q1 		$189K Sell
405
-220
-35% -$1.27K ﹤0.01% 4825
2020
Q4 		$214K Buy
625
+385
+160% +$1.67K ﹤0.01% 4510
2020
Q3 		$126K Buy
240
+229
+2,082% +$1.33K ﹤0.01% 4645
2020
Q2 		$5K Buy
+11
New +$48 ﹤0.01% 6949

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Simplex Trading's CAPR Position: Q1 2026 in Review

Simplex Trading sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 55,707 shares — an estimated $1.48M sold.

Simplex Trading first reported a position in CAPR in Q2 2020 and held it in 17 quarters. The position peaked at $1.61M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Simplex Trading reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 55,707 Capricor Therapeutics shares in Q1 2026, an estimated $1.48M.
  • Simplex Trading first reported a position in Capricor Therapeutics in Q2 2020 and held it in 17 quarters.
  • Simplex Trading's Capricor Therapeutics position peaked at $1.61M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.